Procter & Gamble Health Limited vs Torrent Pharmaceuticals Limited
A side-by-side comparison of Procter & Gamble Health Limited (PGHL) and Torrent Pharmaceuticals Limited (TORNTPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Procter & Gamble Health Limited leads PGHL vs TORNTPHARM on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation40
- Profitability31
- Growth02
- Size & financial health13
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
PGHL takes 4/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
PGHL takes 3/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
TORNTPHARM takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
TORNTPHARM takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has been maintaining a healthy dividend payout of 104.1%", "Company is almost debt free."]
- − ["Stock is trading at 16.46 times its book value"]
- + ["Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 67.6%"]
- − ["Stock is trading at 20.67 times its book value", "Company has a high debt to equity ratio of 1.79."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.